Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial)

被引：1

作者：

Patel, V. ^{[1
]}

Mcphail, M. J. W. ^{[1
]}

Zamalloa, A. ^{[1
]}

Stoy, S. ^{[1
,2
]}

Vijay, G. M. ^{[1
]}

Huang, X. ^{[1
]}

Rogers, G. ^{[3
]}

Choo, J. ^{[3
]}

Edwards, L. ^{[1
]}

Gray, E. ^{[1
]}

Woodhouse, C. ^{[1
]}

Gencer, S. ^{[4
]}

Coen, M. ^{[4
]}

Wendon, J. ^{[1
]}

Bruce, K. ^{[5
]}

Shawcross, D. ^{[1
]}

机构：

[1] Kings Coll London, Fac Life Sci & Med, Sch Immunol & Microbial Sci, James Black Ctr,Liver Sci, 1st Floor, London, England

[2] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark

[3] South Australian Hlth & Med Res Inst, Microbiome Res, Adelaide, SA, Australia

[4] Imperial Coll London, Dept Surg & Canc, Div Computat & Syst Med, Biomol Med, London, England

[5] Kings Coll London, Inst Pharmaceut Sci, 5th Floor Franklin Wilkins Bldg, London, England

来源：

JOURNAL OF HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

10.1016/S0168-8278(18)30432-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LBP-005

引用

页码：S107 / S108

页数：2

共 50 条

[1] A PLACEBO CONTROLLED SINGLE CENTRE DOUBLE BLIND RANDOMISED TRIAL TO INVESTIGATE THE EFFICACY OF RIFAXIMIN IN IMPROVING SYSTEMIC INFLAMMATION AND NEUTROPHIL MALFUNCTION IN PATIENTS WITH CIRRHOSIS AND CHRONIC HEPATIC ENCEPHALOPATHY ('RIFSYS')
Patel, V. C.
Shawcross, D. L.
JOURNAL OF HEPATOLOGY, 2015, 62 : S854 - S854
[2] Lactitol in treatment of subclinical hepatic encephalopathy :a double-blind placebo-controlled randomised trial
石虹
傅志君
朱梁
陈伟忠
Chinese Medical Journal, 1998, (02)
[3] Lactitol in treatment of subclinical hepatic encephalopathy :a double-blind placebo-controlled randomised trial
石虹
傅志君
朱梁
陈伟忠
中华医学杂志(英文版), 1998, (02) : 39 - 39
[4] Lactitol in treatment of subclinical hepatic encephalopathy: a double-blind placebo-controlled randomised trial
Li, HY
Shi, H
Fu, ZJ
Zhu, L
Chen, WZ
CHINESE MEDICAL JOURNAL, 1998, 111 (02) : 135 - 135
[5] Efficacy of pasteurised yoghurt in improving chronic constipation: A randomised, double-blind, placebo-controlled trial
Liu, Zhen-min
Xu, Zhi-yuan
Han, Mei
Guo, Ben-Heng
INTERNATIONAL DAIRY JOURNAL, 2015, 40 : 1 - 5
[6] SAFETY OF RIFAXIMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A RANDOMIZED, PHASE 3, PLACEBO-CONTROLLED CLINICAL TRIAL
Mullen, K.
Sigal, S.
Sheikh, M.
Bass, N.
Poordad, F.
Merchant, K.
Huang, S.
Shaw, A.
Bortey, E.
Forbes, W.
JOURNAL OF HEPATOLOGY, 2009, 50 : S84 - S85
[7] RIFAXIMIN IS EFFECTIVE IN MAINTAINING REMISSION IN HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Bass, N.
Mullen, K.
Sigal, S.
Sanyal, A.
Poordad, F.
Merchant, K.
Huang, S.
Shaw, A.
Bortey, F.
Forbes, W.
JOURNAL OF HEPATOLOGY, 2009, 50 : S39 - S39
[8] Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
Sanyal, A.
Younossi, Z. M.
Bass, N. M.
Mullen, K. D.
Poordad, F.
Brown, R. S.
Vemuru, R. P.
Jamal, M. Mazen
Huang, S.
Merchant, K.
Bortey, E.
Forbes, W. P.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 853 - 861
[9] RIFAXIMIN TREATMENT IMPROVED QUALITY OF LIFE IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A LARGE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Sanyal, A.
Bass, N.
Mullen, K.
Poordad, F.
Shaw, A.
Merchant, K.
Bortey, E.
Forbes, W. P.
Huang, S.
JOURNAL OF HEPATOLOGY, 2010, 52 : S7 - S7
[10] Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial
Groeneweg, M
Gyr, K
Amrein, R
ScolloLavizzari, G
Williams, R
Yoo, JY
Schalm, SW
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1996, 98 (01): : 29 - 34

← 1 2 3 4 5 →